Petros Pharmaceuticals, Inc.
PTPI
$0.01
$0.000.81%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.07M | 7.32M | 8.93M | 3.71M | 3.89M |
| Total Receivables | -- | -- | -- | 416.10K | 1.95M |
| Inventory | -- | -- | -- | 3.00M | 3.05M |
| Prepaid Expenses | 63.20K | 75.30K | 53.40K | 162.70K | 404.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 5.48M | 6.50K | 1.42M |
| Total Current Assets | 6.13M | 7.40M | 14.47M | 7.29M | 10.72M |
|
|
|||||
| Total Current Assets | 6.13M | 7.40M | 14.47M | 7.29M | 10.72M |
| Net Property, Plant & Equipment | -- | -- | -- | 136.70K | 143.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 3.20M | 6.83M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 3.14M | -- | 3.00M |
| Total Assets | 6.13M | 7.40M | 17.61M | 10.64M | 20.69M |
|
|
|||||
| Total Accounts Payable | 421.10K | 970.00K | 756.70K | 2.33M | 1.60M |
| Total Accrued Expenses | 512.00K | 260.60K | 199.70K | 1.29M | 1.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 7.31M | 2.33M |
| Total Finance Division Other Current Liabilities | 1.83M | 1.72M | 26.18M | 7.10M | 7.40M |
| Total Other Current Liabilities | 1.83M | 1.72M | 26.18M | 7.10M | 7.40M |
| Total Current Liabilities | 2.77M | 2.95M | 27.13M | 18.03M | 12.56M |
|
|
|||||
| Total Current Liabilities | 2.77M | 2.95M | 27.13M | 18.03M | 12.56M |
| Long-Term Debt | -- | -- | -- | -- | 4.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 75.20K | 91.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 57.60K | -- | -- |
| Total Liabilities | 2.77M | 2.95M | 27.19M | 18.10M | 17.58M |
|
|
|||||
| Common Stock & APIC | 114.33M | 114.48M | 105.88M | 105.74M | 107.05M |
| Retained Earnings | -110.96M | -110.04M | -115.47M | -113.21M | -103.93M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.37M | 4.45M | -9.58M | -7.47M | 3.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 1.40K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 1.40K |
|
|
|||||
| Total Common Equity | 3.37M | 4.45M | -9.58M | -7.47M | 3.12M |
| Total Preferred Equity | -- | -- | -- | -- | 1.40K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.37M | 4.45M | -9.58M | -7.47M | 3.12M |
|
|
|||||